These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 10541867)

  • 1. Disease associated prion protein may deposit in the peripheral nervous system in human transmissible spongiform encephalopathies.
    Hainfellner JA; Budka H
    Acta Neuropathol; 1999 Nov; 98(5):458-60. PubMed ID: 10541867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deposition of disease-associated prion protein involves the peripheral nervous system in experimental scrapie.
    Groschup MH; Beekes M; McBride PA; Hardt M; Hainfellner JA; Budka H
    Acta Neuropathol; 1999 Nov; 98(5):453-7. PubMed ID: 10541866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. Part II].
    Zaborowski A
    Psychiatr Pol; 2004; 38(2):297-309. PubMed ID: 15307294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prion diseases or transmissible spongiform encephalopathies].
    Brandel JP
    Rev Med Interne; 2022 Feb; 43(2):106-115. PubMed ID: 34148672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical characteristics and diagnostics of human spongiform encephalopathies: an update].
    Hermann P; Goebel S; Zerr I
    Nervenarzt; 2024 Apr; 95(4):376-384. PubMed ID: 38503894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of the peripheral nervous system in human prion diseases including dural graft associated Creutzfeldt-Jakob disease.
    Ishida C; Okino S; Kitamoto T; Yamada M
    J Neurol Neurosurg Psychiatry; 2005 Mar; 76(3):325-9. PubMed ID: 15716520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prions in the peripheral nerves of bovine spongiform encephalopathy-affected cattle.
    Masujin K; Matthews D; Wells GAH; Mohri S; Yokoyama T
    J Gen Virol; 2007 Jun; 88(Pt 6):1850-1858. PubMed ID: 17485547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human prion diseases: from Kuru to variant Creutzfeldt-Jakob disease.
    Sikorska B; Liberski PP
    Subcell Biochem; 2012; 65():457-96. PubMed ID: 23225013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases).
    Budka H; Aguzzi A; Brown P; Brucher JM; Bugiani O; Gullotta F; Haltia M; Hauw JJ; Ironside JW; Jellinger K
    Brain Pathol; 1995 Oct; 5(4):459-66. PubMed ID: 8974629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic and infectious prion diseases.
    Prusiner SB
    Arch Neurol; 1993 Nov; 50(11):1129-53. PubMed ID: 8105771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toluidine blue-O staining of prion protein deposits.
    Sánchez A; Guzmán A; Ortiz A; Rembao D; Espinosa B; Zenteno E; Guevara J
    Histochem Cell Biol; 2001 Dec; 116(6):519-24. PubMed ID: 11810193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a second bovine amyloidotic spongiform encephalopathy: molecular similarities with sporadic Creutzfeldt-Jakob disease.
    Casalone C; Zanusso G; Acutis P; Ferrari S; Capucci L; Tagliavini F; Monaco S; Caramelli M
    Proc Natl Acad Sci U S A; 2004 Mar; 101(9):3065-70. PubMed ID: 14970340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. Part I].
    Zaborowski A
    Psychiatr Pol; 2004; 38(2):283-96. PubMed ID: 15307293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human transmissible spongiform encephalopathies: historic view.
    Asher DM; Gregori L
    Handb Clin Neurol; 2018; 153():1-17. PubMed ID: 29887130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From slow virus to prion: a review of transmissible spongiform encephalopathies.
    Lantos PL
    Histopathology; 1992 Jan; 20(1):1-11. PubMed ID: 1531331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partitioning of human and sheep forms of the pathogenic prion protein during the purification of therapeutic proteins from human plasma.
    Stenland CJ; Lee DC; Brown P; Petteway SR; Rubenstein R
    Transfusion; 2002 Nov; 42(11):1497-500. PubMed ID: 12421224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterisation of new monoclonal antibodies reacting with prions from both human and animal brain tissues.
    Cordes H; Bergström AL; Ohm J; Laursen H; Heegaard PM
    J Immunol Methods; 2008 Sep; 337(2):106-20. PubMed ID: 18657541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thienyl pyrimidine derivatives with PrP(Sc) oligomer-inducing activity are a promising tool to study prions.
    Imberdis T; Ayrolles-Torro A; Verdier JM; Perrier V
    Curr Top Med Chem; 2013; 13(19):2477-83. PubMed ID: 24059332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular biology and pathogenesis of prion diseases.
    Prusiner SB
    Trends Biochem Sci; 1996 Dec; 21(12):482-7. PubMed ID: 9009832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropathology and molecular biology of variant Creutzfeldt-Jakob disease.
    Ironside JW; Head MW
    Curr Top Microbiol Immunol; 2004; 284():133-59. PubMed ID: 15148991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.